Day: February 26, 2025

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) — Hydreight Technologies Inc. (TSXV: NURS) (“Hydreight” or the “Company“), a North American, fully integrated, mobile clinical network of nurses, doctors, and pharmacy distribution, is pleased to announce that, further to the news releases of the Company dated February 10, 2025, and February 18, 2025, it has closed its previously announced commercially reasonable “best efforts” private placement with Beacon Securities Limited (the “Agent“) acting as the sole agent. The Company issued 3,492,300 units of the Company (each, a “Unit“) at a price of $1.55 per Unit for aggregate gross proceeds of $5,413,065 (the “Offering”). The Offering...

Seasoned U.S. Department of Defence executive brings more than 40 years of military and public sector experience as the Company advances strategic rare earth asset NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading mining development company focused on critical metals and minerals and producing strategic products essential to electrification and next generation technologies for Europe and its western world partners, today announced that Michael C. Ryan has been appointed to serve as an independent director on the Company’s Board, effective March 1, 2025. Mr. Ryan will serve as Chairman of the Audit Committee and with his appointment, Critical Metals Corp’s Board is comprised of five directors. Mr. Ryan brings a unique blend of experience to Critical...

LOS ANGELES, Feb. 26, 2025 (GLOBE NEWSWIRE) — Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announces that it has $15 million in additional equity committed at a price per share of $1.00 and one privately placed cash warrant exercisable at $1.50 with a one year term. David Weinstein, Chief Executive Officer of Renovaro, commented, “We believe this new capital now enables the company to accelerate our focus on revolutionizing healthcare by combining advanced diagnostic and personalized immunotherapy for early diagnosis, better-targeted treatments, and drug discovery.” About Renovaro Renovaro https://renovarogroup.com/ aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early...

Summary Freight revenues were NOK 148.0 million in Q4 2024, at the same level as the corresponding period last year and an increase of NOK 7.1 million compared to the previous quarter.  The average rate is higher this quarter than the previous quarter, and utilization is on same level as the previous quarter. Operating expenses were NOK 87.7 million in Q4 2024, a decrease compared to Q4 2023 of NOK 1.6 million and an increase compared to the previous quarter of NOK 6.5 million. The company achieved an operating income before depreciation of NOK 68.2 million in Q4 2024, compared with NOK 72.9 million in Q4 2023. No impairment charges or reversals of previous impairment charges were made in the fourth quarter. In the fourth quarter last year, previous impairment charges were reversed by NOK 400.0 million. Value adjustment of the company’s...

Lassila & Tikanoja plcStock Exchange Release26 February, 2025 at 4.05 p.m. Lassila & Tikanoja Oyj – Managers’ Transactions____________________________________________ Person subject to the notification requirementName: Eero HautaniemiPosition: Chief Executive OfficerIssuer: Lassila & Tikanoja OyjLEI: 743700Z9Z54VGHZA0028Notification type: INITIAL NOTIFICATIONReference number: 97790/5/4____________________________________________ Transaction date: 2025-02-25Outside a trading venueInstrument type: SHAREISIN: FI0009010854Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 3691 Unit price: 0 EUR Aggregated transactions (1):Volume: 3691 Volume weighted average price: 0 EURLASSILA & TIKANOJA PLC Hilppa RautpaloGeneral Counsel For additional information, please contactHilppa...

WASHINGTON, Feb. 26, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the expansion of its Food & Agribusiness practice with the appointment of Lauren Chupp as a Senior Managing Director within the Corporate Finance & Restructuring segment. Ms. Chupp, who is based in Atlanta, is an experienced advisor to the global food and agriculture industry with nearly two decades of experience in strategy, transactions and transformation services, helping clients navigate the rapidly changing food and agriculture industry. Ms. Chupp specializes in the areas of corporate growth and portfolio strategy; digital and data strategy; transaction services including M&A strategy, diligence and integration planning; and business transformation orchestration encompassing complex, multidisciplinary teams and business...